An umbrella MoU signed to apply Aganitha’s Generative AI solutions for small molecule and antibody design for translation of CCMB’s R&D findings into therapeutic candidates Multiple targets for Malaria and TB to be addressed in the initial phase of collaboration Design of research antibodies for furthering neurology investigations also in progress May 29, 2024, Hyderabad,… Continue reading Combining Deep Science with Deep Tech: CSIR-CCMB and Aganitha sign a framework agreement to apply Generative AI for therapeutic design and research in multiple disease areas